These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

747 related items for PubMed ID: 12394282

  • 1. Increased ethanol self-administration and anxiety-like behavior during acute ethanol withdrawal and protracted abstinence: regulation by corticotropin-releasing factor.
    Valdez GR, Roberts AJ, Chan K, Davis H, Brennan M, Zorrilla EP, Koob GF.
    Alcohol Clin Exp Res; 2002 Oct; 26(10):1494-501. PubMed ID: 12394282
    [Abstract] [Full Text] [Related]

  • 2. Increased anxiety-like behavior and ethanol self-administration in dependent rats: reversal via corticotropin-releasing factor-2 receptor activation.
    Valdez GR, Sabino V, Koob GF.
    Alcohol Clin Exp Res; 2004 Jun; 28(6):865-72. PubMed ID: 15201629
    [Abstract] [Full Text] [Related]

  • 3. Effects of neuropeptide Y and corticotropin-releasing factor on ethanol intake in Wistar rats: interaction with chronic ethanol exposure.
    Thorsell A, Slawecki CJ, Ehlers CL.
    Behav Brain Res; 2005 Jun 03; 161(1):133-40. PubMed ID: 15904720
    [Abstract] [Full Text] [Related]

  • 4. Antagonism of corticotropin-releasing factor attenuates the enhanced responsiveness to stress observed during protracted ethanol abstinence.
    Valdez GR, Zorrilla EP, Roberts AJ, Koob GF.
    Alcohol; 2003 Feb 03; 29(2):55-60. PubMed ID: 12782246
    [Abstract] [Full Text] [Related]

  • 5. Remission and resurgence of anxiety-like behavior across protracted withdrawal stages in ethanol-dependent rats.
    Zhao Y, Weiss F, Zorrilla EP.
    Alcohol Clin Exp Res; 2007 Sep 03; 31(9):1505-15. PubMed ID: 17760785
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization of a novel and potent corticotropin-releasing factor antagonist in rats.
    Menzaghi F, Howard RL, Heinrichs SC, Vale W, Rivier J, Koob GF.
    J Pharmacol Exp Ther; 1994 May 03; 269(2):564-72. PubMed ID: 8182523
    [Abstract] [Full Text] [Related]

  • 8. Changes in levels of regional CRF-like-immunoreactivity and plasma corticosterone during protracted drug withdrawal in dependent rats.
    Zorrilla EP, Valdez GR, Weiss F.
    Psychopharmacology (Berl); 2001 Dec 03; 158(4):374-81. PubMed ID: 11797058
    [Abstract] [Full Text] [Related]

  • 9. Corticotropin-releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats.
    Funk CK, O'Dell LE, Crawford EF, Koob GF.
    J Neurosci; 2006 Nov 01; 26(44):11324-32. PubMed ID: 17079660
    [Abstract] [Full Text] [Related]

  • 10. Increased drinking during withdrawal from intermittent ethanol exposure is blocked by the CRF receptor antagonist D-Phe-CRF(12-41).
    Finn DA, Snelling C, Fretwell AM, Tanchuck MA, Underwood L, Cole M, Crabbe JC, Roberts AJ.
    Alcohol Clin Exp Res; 2007 Jun 01; 31(6):939-49. PubMed ID: 17403068
    [Abstract] [Full Text] [Related]

  • 11. Dansyl-PQRamide, a putative antagonist of NPFF receptors, reduces anxiety-like behavior of ethanol withdrawal in a plus-maze test in rats.
    Kotlinska J, Pachuta A, Bochenski M, Silberring J.
    Peptides; 2009 Jun 01; 30(6):1165-72. PubMed ID: 19463751
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Time-dependent induction of anxiogenic-like effects after central infusion of urocortin or corticotropin-releasing factor in the rat.
    Spina MG, Merlo-Pich E, Akwa Y, Balducci C, Basso AM, Zorrilla EP, Britton KT, Rivier J, Vale WW, Koob GF.
    Psychopharmacology (Berl); 2002 Mar 01; 160(2):113-21. PubMed ID: 11875628
    [Abstract] [Full Text] [Related]

  • 16. Antagonism of CRF receptors prevents the deficit in brain reward function associated with precipitated nicotine withdrawal in rats.
    Bruijnzeel AW, Zislis G, Wilson C, Gold MS.
    Neuropsychopharmacology; 2007 Apr 01; 32(4):955-63. PubMed ID: 16943772
    [Abstract] [Full Text] [Related]

  • 17. Corticotropin-releasing hormone receptor 1 antagonist blocks brain-gut activation induced by colonic distention in rats.
    Saito K, Kasai T, Nagura Y, Ito H, Kanazawa M, Fukudo S.
    Gastroenterology; 2005 Nov 01; 129(5):1533-43. PubMed ID: 16285953
    [Abstract] [Full Text] [Related]

  • 18. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L, Liu D, Ceng X, Ma L.
    Eur J Neurosci; 2000 Dec 01; 12(12):4398-404. PubMed ID: 11122350
    [Abstract] [Full Text] [Related]

  • 19. Differential activation of CRF receptor subtypes removes stress-induced memory deficit and anxiety.
    Todorovic C, Radulovic J, Jahn O, Radulovic M, Sherrin T, Hippel C, Spiess J.
    Eur J Neurosci; 2007 Jun 01; 25(11):3385-97. PubMed ID: 17553007
    [Abstract] [Full Text] [Related]

  • 20. Repeated intracerebral teneurin C-terminal associated peptide (TCAP)-1 injections produce enduring changes in behavioral responses to corticotropin-releasing factor (CRF) in rat models of anxiety.
    Tan LA, Xu K, Vaccarino FJ, Lovejoy DA, Rotzinger S.
    Behav Brain Res; 2008 Mar 17; 188(1):195-200. PubMed ID: 18082275
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 38.